AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Grulich, AE Law, MG
Citation: Ae. Grulich et Mg. Law, Long-term high-dose acyclovir and AIDS-related non-Hodgkins lymphoma, CLIN INF D, 32(6), 2001, pp. 989-990

Authors: Law, MG Lynskey, M Ross, J Hall, W
Citation: Mg. Law et al., Back-projection estimates of the number of dependent heroin users in Australia, ADDICTION, 96(3), 2001, pp. 433-443

Authors: Freeman, AJ Dore, GJ Law, MG Thorpe, M Von Overbeck, J Lloyd, AR Marinos, G Kaldor, JM
Citation: Aj. Freeman et al., Estimating progression to cirrhosis in chronic hepatitis C virus infection, HEPATOLOGY, 34(4), 2001, pp. 809-816

Authors: Grulich, AE Li, YM McDonald, AM Correll, PK Law, MG Kaldor, JM
Citation: Ae. Grulich et al., Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the eraof potent combination antiretroviral therapy, AIDS, 15(5), 2001, pp. 629-633

Authors: Law, MG Prestage, G Grulich, A Van de Ven, P Kippax, S
Citation: Mg. Law et al., Modelling the effect of combination antiretroviral treatments on HIV incidence, AIDS, 15(10), 2001, pp. 1287-1294

Authors: Shiell, A Law, MG
Citation: A. Shiell et Mg. Law, The cost of hepatitis C and the cost-effectiveness of its prevention, HEALTH POLI, 58(2), 2001, pp. 121-131

Authors: Correll, PK Law, MG Seed, CR Gust, A Buring, M Dax, EM Keller, AJ Kaldor, JM
Citation: Pk. Correll et al., Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies, VOX SANGUIN, 81(1), 2001, pp. 6-11

Authors: Smith, D Goggin, L Meldrum, H Phillips, S Russell, D Bloch, M Bodsworth, NJ Roth, N Law, MG
Citation: D. Smith et al., Capturing the paradigm shift in HIV treatment: changing attitudes in the choice of combination antiretroviral drugs by high HIV caseload Australian GPs (1996-1997), AIDS CARE, 12(1), 2000, pp. 41-47

Authors: Grulich, AE Wan, XN Law, MG Milliken, ST Lewis, CR Garsia, RJ Gold, J Finlayson, RJ Cooper, DA Kaldor, JM
Citation: Ae. Grulich et al., B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS, AIDS, 14(2), 2000, pp. 133-140

Authors: Law, MG Li, YM McDonald, AM Cooper, DA Kaldor, JM
Citation: Mg. Law et al., Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection, AIDS, 14(2), 2000, pp. 197-201

Authors: Miller, J Carr, A Smith, D Emery, S Law, MG Grey, P Cooper, DA
Citation: J. Miller et al., Lipodystrophy following antiretroviral therapy of primary HIV infection, AIDS, 14(15), 2000, pp. 2406-2407

Authors: Law, MG Roberts, SK Dore, GJ Kaldor, JM
Citation: Mg. Law et al., Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality, MED J AUST, 173(8), 2000, pp. 403

Authors: Hall, WD Ross, JE Lynskey, MT Law, MG Degenhardt, LJ
Citation: Wd. Hall et al., How many dependent heroin users are there in Australia?, MED J AUST, 173(10), 2000, pp. 528-531

Authors: Losso, MH Belloso, WH Emery, S Benetucci, JA Cahn, PE Lasala, MC Lopardo, G Salomon, H Saracco, M Nelson, E Law, MG Davey, RT Allende, MC Lane, HC
Citation: Mh. Losso et al., A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4(+) cell counts >=350/mm(3), J INFEC DIS, 181(5), 2000, pp. 1614-1621

Authors: Law, MG Anderson, J Cui, JS Duncombe, C Mallal, S Roth, N Fagan, D Smith, D Bloch, M Grulich, A
Citation: Mg. Law et al., Trends in antiretroviral treatment for people with HIV in Australia: an observational database pilot study, VENEREOLOGY, 12(3), 1999, pp. 97-103

Authors: Law, MG
Citation: Mg. Law, Modelling the hepatitis C virus epidemic in Australia, J GASTR HEP, 14(11), 1999, pp. 1100-1107

Authors: Grulich, AE Wan, XN Law, MG Coates, M Kaldor, JM
Citation: Ae. Grulich et al., Risk of cancer in people with AIDS, AIDS, 13(7), 1999, pp. 839-843

Authors: Law, MG de Winter, L McDonald, A Cooper, DA Kaldor, JM
Citation: Mg. Law et al., AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment, AIDS, 13(2), 1999, pp. 263-269

Authors: Collins, S Law, MG Fletcher, A Boyd, A Kaldor, J Masters, CL
Citation: S. Collins et al., Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study, LANCET, 353(9154), 1999, pp. 693-697

Authors: Dore, GJ Law, MG Kaldor, JM
Citation: Gj. Dore et al., Prevalence of hepatitis C virus infection in the United States., N ENG J MED, 341(27), 1999, pp. 2093-2094

Authors: Correll, PK Law, MG McDonald, AM Cooper, DA Kaldor, JM
Citation: Pk. Correll et al., HIV disease progression in Australia in the time of combination antiretroviral therapies, MED J AUST, 170(6), 1999, pp. 285-285

Authors: Correll, PK Law, MG McDonald, AM Cooper, DA Kaldor, JM
Citation: Pk. Correll et al., HIV disease progression in Australia in the time of combination antiretroviral therapies, MED J AUST, 169(9), 1998, pp. 469-472
Risultati: 1-22 |